Zhu Y, Zhang W, Dimagli A, et al. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ 2024;385:e075707. SS. Dual antiplatelet therapy after ...

The rate of the composite of death and coronary revascularization was also lower in the CABG group, partly because 17% of the medical-therapy patients crossed over to CABG during follow-up.

Given that most CABG operations today use SVGs to supplement grafting of the left internal thoracic artery (LITA)—and that upwards of 25% of them fail after 1 year and as many as 50% fail by 10 ...

Patients with non-STEMI and either left main or multivessel coronary disease who underwent optimized medical therapy had worse outcomes compared with those who underwent CABG or PCI, according to ...

The latest meta-analysis included 11 randomized, controlled clinical trials with 984 patients undergoing on- or off-pump CABG surgery. Of these studies, six included patients treated with 20 mg or ...